Lexaria Bioscience Corp.
LEXX
$0.58
-$0.10-14.96%
NASDAQ
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.97M | 4.63M | 6.54M | 8.12M | 6.56M |
| Total Receivables | 368.40K | 358.10K | 331.20K | 263.50K | 154.50K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.13M | 823.30K | 850.40K | 444.10K | 1.19M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.47M | 5.81M | 7.72M | 8.83M | 7.90M |
|
|
|||||
| Total Current Assets | 3.47M | 5.81M | 7.72M | 8.83M | 7.90M |
| Net Property, Plant & Equipment | 334.90K | 354.20K | 383.00K | 398.60K | 389.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 307.80K | 516.40K | 506.20K | 505.40K | 516.70K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 64.00K | 64.00K | 64.00K | 64.00K | 63.60K |
| Total Assets | 4.18M | 6.74M | 8.68M | 9.79M | 8.87M |
|
|
|||||
| Total Accounts Payable | 569.80K | 597.50K | 1.28M | 262.10K | 379.90K |
| Total Accrued Expenses | 893.30K | 860.80K | 514.40K | 6.90K | 686.50K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 30.40K | 29.90K | 29.30K | 28.80K | 28.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 5.00K |
| Total Other Current Liabilities | -- | -- | -- | -- | 5.00K |
| Total Current Liabilities | 1.49M | 1.49M | 1.82M | 297.80K | 1.10M |
|
|
|||||
| Total Current Liabilities | 1.49M | 1.49M | 1.82M | 297.80K | 1.10M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 78.90K | 86.70K | 94.40K | 101.90K | 109.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.57M | 1.57M | 1.92M | 399.70K | 1.21M |
|
|
|||||
| Common Stock & APIC | 66.52M | 66.40M | 64.24M | 64.06M | 59.62M |
| Retained Earnings | -63.46M | -60.76M | -56.98M | -54.26M | -51.56M |
| Treasury Stock & Other | -70.30K | -81.10K | -118.20K | -23.00K | -19.80K |
| Total Common Equity | 2.99M | 5.55M | 7.14M | 9.77M | 8.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.99M | 5.55M | 7.14M | 9.77M | 8.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -386.90K | -385.60K | -384.00K | -380.30K | -377.30K |
| Total Equity | 2.60M | 5.17M | 6.76M | 9.39M | 7.66M |
|
|
|||||